These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25636236)

  • 1. Randomized clinical trials as reflexive-interpretative process in patients with rheumatoid arthritis: a qualitative study.
    de Jorge M; Parra S; de la Torre-Aboki J; Herrero-Beaumont G
    Rheumatol Int; 2015 Aug; 35(8):1423-30. PubMed ID: 25636236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of Patient Decision-Making Regarding Medical Treatment of Rheumatoid Arthritis.
    Mathews AL; Coleska A; Burns PB; Chung KC
    Arthritis Care Res (Hoboken); 2016 Mar; 68(3):318-24. PubMed ID: 26315611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of rheumatoid arthritis in Turkey: a questionnaire study.
    Direskeneli H; Akkoç N; Bes C; Cakir N; Cefle A; Cobankara V; Dalkilic E; Dinc A; Ertenli I; Gul A; Hamuryudan V; Inanc M; Kalyoncu U; Karaaslan Y; Kasifoglu T; Keser G; Keskin G; Kisacik B; Kiraz S; Masatlioglu S; Onat AM; Ozbek S; Ozturk MA; Pamuk ON; Pay S; Pirildar T; Sayarlioglu M; Senel S; Senturk T; Tasan D; Terzioglu E; Yazici A; Yucel E
    Clin Exp Rheumatol; 2014; 32(4):477-83. PubMed ID: 24960289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient decision-making related to antirheumatic drugs in rheumatoid arthritis: the importance of patient trust of physician.
    Martin RW; Head AJ; René J; Swartz TJ; Fiechtner JJ; McIntosh BA; Holmes-Rovner M
    J Rheumatol; 2008 Apr; 35(4):618-24. PubMed ID: 18278840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a Web-Based Patient Decision Aid on Biologic and Small-Molecule Agents for Rheumatoid Arthritis: Results From a Proof-of-Concept Study.
    Li LC; Shaw CD; Lacaille D; Yacyshyn E; Jones CA; Koehn C; Hoens AM; Geldman J; Sayre EC; Macdonald GG; Leese J; Bansback N
    Arthritis Care Res (Hoboken); 2018 Mar; 70(3):343-352. PubMed ID: 28544648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Information and participation in decision-making about treatment: a qualitative study of the perceptions and preferences of patients with rheumatoid arthritis.
    Schildmann J; Grunke M; Kalden JR; Vollmann J
    J Med Ethics; 2008 Nov; 34(11):775-9. PubMed ID: 18974408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of patient knowledge on rheumatoid arthritis in the range of their own disease--preliminary study.
    Pytel A; Wrzosek Z
    Adv Clin Exp Med; 2012; 21(3):343-51. PubMed ID: 23214198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
    Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
    Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why do - or don't - patients with urinary tract infection participate in a clinical trial? A qualitative study in German family medicine.
    Bleidorn J; Bucak S; Gágyor I; Hummers-Pradier E; Dierks ML
    Ger Med Sci; 2015; 13():Doc17. PubMed ID: 26512232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complexity of the treatment: the decision-making process among women with rheumatoid arthritis.
    Salt E; Peden A
    Qual Health Res; 2011 Feb; 21(2):214-22. PubMed ID: 20798264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life and continuation rate on first-line anti-tumour necrosis factor therapy among rheumatoid arthritis patients from the Australian Rheumatology Association Database.
    Staples MP; March L; Lassere M; Reid C; Buchbinder R
    Rheumatology (Oxford); 2011 Jan; 50(1):166-75. PubMed ID: 20929971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
    Ciubotariu E; Gabay C; Finckh A;
    J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients or research subjects? A qualitative study of participation in a randomised controlled trial of a complex intervention.
    Heaven B; Murtagh M; Rapley T; May C; Graham R; Kaner E; Thomson R
    Patient Educ Couns; 2006 Aug; 62(2):260-70. PubMed ID: 16181766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician Preferences and Variations in Prescription of Biologic Drugs for Rheumatoid Arthritis: A Register-Based Study of 4,010 Patients in Sweden.
    Kalkan A; Husberg M; Hallert E; Roback K; Thyberg I; Skogh T; Carlsson P
    Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1679-85. PubMed ID: 26097219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What outcomes from pharmacologic treatments are important to people with rheumatoid arthritis? Creating the basis of a patient core set.
    Sanderson T; Morris M; Calnan M; Richards P; Hewlett S
    Arthritis Care Res (Hoboken); 2010 May; 62(5):640-6. PubMed ID: 20461785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formative research in clinical trial development: attitudes of patients with arthritis in enhancing prevention trials.
    Taylor HA; Sugarman J; Pisetsky DS; Bathon J
    Ann Rheum Dis; 2007 Apr; 66(4):542-4. PubMed ID: 16984939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of a group-based intervention to change medication beliefs and improve medication adherence in patients with rheumatoid arthritis: a randomized controlled trial.
    Zwikker HE; van den Ende CH; van Lankveld WG; den Broeder AA; van den Hoogen FH; van de Mosselaar B; van Dulmen S; van den Bemt BJ
    Patient Educ Couns; 2014 Mar; 94(3):356-61. PubMed ID: 24388126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of a rheumatoid arthritis disease therapy management program focusing on medication adherence.
    Stockl KM; Shin JS; Lew HC; Zakharyan A; Harada AS; Solow BK; Curtis BS
    J Manag Care Pharm; 2010 Oct; 16(8):593-604. PubMed ID: 20866164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continued participation in a ten-year tight control treat-to-target study in rheumatoid arthritis: why keep patients doing their best?
    Markusse IM; Dirven L; Han KH; Ronday HK; Kerstens PJ; Lems WF; Huizinga TW; Allaart CF
    Arthritis Care Res (Hoboken); 2015 May; 67(6):739-45. PubMed ID: 25581505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German biologics register RABBIT.
    Gerhold K; Richter A; Schneider M; Bergerhausen HJ; Demary W; Liebhaber A; Listing J; Zink A; Strangfeld A
    Rheumatology (Oxford); 2015 Oct; 54(10):1858-66. PubMed ID: 26001633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.